2192.HK Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 май 2024 @ 11:08):

Medlive Technology Co., Ltd., together with its subsidiaries, operates an online professional physician platform in Mainland China and internationally...

Stats
Объем за сегодня	585 000
Средний объем	489 667
Рыночная капитализация	6.32B
EPS	HKD0 ( 2024-03-25 )
Дата следующего отчета о доходах	( HKD0 ) 2024-05-24
Last Dividend	HKD0.0747 ( 2023-06-13 )
Next Dividend	HKD0 ( N/A )
P/E	24.17
ATR14	HKD0.0150 (0.17%)

Объем Корреляция

Длинно: 0.23 (neutral)

Кратко: 0.41 (neutral)

Signal:(54.483) Neutral

Medlive Technology Co., Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Medlive Technology Co., Корреляция - Валюта/Сырье

-0.68
( moderate negative )

-0.03
( neutral )

0.00
( neutral )

-0.25
( neutral )

0.33
( neutral )

0.64
( weak )

Medlive Technology Co., Финансовые показатели

Annual	2023
Выручка:	HKD412.00M
Валовая прибыль:	HKD251.34M (61.00 %)
EPS:	HKD0.340

FY	2023
Выручка:	HKD412.00M
Валовая прибыль:	HKD251.34M (61.00 %)
EPS:	HKD0.340

FY	2022
Выручка:	HKD314.05M
Валовая прибыль:	HKD212.74M (67.74 %)
EPS:	HKD0.160

FY	2021
Выручка:	HKD284.44M
Валовая прибыль:	HKD200.73M (70.57 %)
EPS:	HKD0.0659

Financial Reports:

No articles found.

Medlive Technology Co., Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.0747 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Medlive Technology Co., Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 2.62 - Decrease likely (47.60%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.0209	2022-06-14
Last Dividend	HKD0.0747	2023-06-13
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	HKD0.0956	--
Avg. Dividend % Per Year	0.00%	--
Score	2.63	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	2.62
Div. Directional Score	7.01	--

Next Divdend (Est)
(2025-03-31)

HKD0 Estimate 3.00 %

Dividend Stability

0.24 Very Poor

Dividend Score

2.63

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
1598.HK	Ex Dividend Junior	2023-07-13	Annually	0.00%
0635.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
9979.HK	Ex Dividend Knight	2023-07-11	Semi-Annually	0.00%
2182.HK	Ex Dividend Junior	2023-06-12	Annually	0.00%
1181.HK	Ex Dividend Knight	2023-09-13	Annually	0.00%
0251.HK	Ex Dividend Junior	2023-09-20	Semi-Annually	0.00%
3899.HK	Ex Dividend Knight	2023-05-24	Annually	0.00%
1755.HK	Ex Dividend Knight	2023-07-03	Annually	0.00%
0788.HK	Ex Dividend Junior	2023-05-16	Annually	0.00%
2342.HK	Ex Dividend Knight	2023-09-07	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.588	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0495	1.200	8.35	10.00	[0 - 0.3]
returnOnEquityTTM	0.0527	1.500	-0.526	-0.789	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	24.10	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	24.01	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	22.97	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00167	-1.500	9.97	-10.00	[0 - 0.6]
interestCoverageTTM	294.76	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.0414	2.00	9.99	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0409	2.00	9.98	10.00	[0 - 20]
debtEquityRatioTTM	0.00178	-1.500	9.99	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.610	1.000	3.17	3.17	[0.2 - 0.8]
operatingProfitMarginTTM	0.158	1.000	8.84	8.84	[0.1 - 0.6]
cashFlowToDebtRatioTTM	3.70	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.0842	0.800	-2.77	-2.22	[0.5 - 2]
Total Score				11.40

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	23.72	1.000	7.70	0	[1 - 100]
returnOnEquityTTM	0.0527	2.50	-0.338	-0.789	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0409	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	2.43	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0414	2.00	9.99	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.568	1.500	-7.12	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0736	1.000	-0.660	0	[0.1 - 0.5]
Total Score				2.62

Medlive Technology Co.,

Medlive Technology Co., Ltd., together with its subsidiaries, operates an online professional physician platform in Mainland China and internationally. Its precision marketing and corporate solution provides full service on its one-site platform, which includes project management, clinical monitoring, clinical data management, biostatistics, protocol design, medical monitoring, patient recruitment, and supporting system, as well as digital market research, electronic data capture, real-world studies, and application software development services. The company's medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians, other registered users, such as other healthcare professionals and pharmaceutical companies. Its intelligent patient management solution provides chronic disease management services, comprising online patient consultation, prescription services, and patient management through Internet hospital; and condition-specific patient education services, which includes content development, application software development, and other related services. The company was formerly known as Kingyee Co., Limited and changed its name to Medlive Technology Co., Ltd. in 2021. Medlive Technology Co., Ltd. was founded in 1996 and is headquartered in Beijing, China.